LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

Search

Moleculin Biotech Inc

Geschlossen

0.4 5.26

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.33

Max

0.41

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+1702.7% upside

Moleculin Biotech Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Sept. 2025, 23:56 UTC

Heiße Aktien

Stocks to Watch: FedEx, 22nd Century, Scholastic

18. Sept. 2025, 22:01 UTC

Wichtige Markttreiber

22nd Century Group Shares Gain on Debt Repayment, New Capital

18. Sept. 2025, 20:51 UTC

Akquisitionen, Fusionen, Übernahmen

UPS Terminates Plan to Buy Estafeta

18. Sept. 2025, 20:31 UTC

Ergebnisse

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping -- Update

18. Sept. 2025, 20:26 UTC

Ergebnisse

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping

18. Sept. 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18. Sept. 2025, 23:43 UTC

Market Talk

Nikkei May Rise on U.S. Stock Gains, Weaker Yen -- Market Talk

18. Sept. 2025, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

18. Sept. 2025, 23:40 UTC

Market Talk

Gold Edges Lower Amid Cautious Mood -- Market Talk

18. Sept. 2025, 23:31 UTC

Market Talk

FedEx Says U.S. Demand Is Resilient -- Market Talk

18. Sept. 2025, 22:03 UTC

Ergebnisse

FedEx Expects Trade Environment to Create $1B Headwind in 2026, CFO Says

18. Sept. 2025, 22:01 UTC

Ergebnisse

FedEx CFO: Asia-to-U.S. Declines Drove $150M International Export Headwind

18. Sept. 2025, 21:56 UTC

Ergebnisse

Lennar Missed Revenue Estimates. The Stock Is Down. -- Barrons.com

18. Sept. 2025, 21:54 UTC

Ergebnisse

FedEx Focused on Demand From Southeast Asia, Europe Amid China Shipping Slowdown, Customer Chief Says

18. Sept. 2025, 21:48 UTC

Ergebnisse

FedEx International Export Volumes Declined, Especially on China-to-U.S. Lane, Exec Says

18. Sept. 2025, 21:47 UTC

Ergebnisse

FedEx Had 5% Increase in U.S. Domestic Average Daily Package Volume in 1Q, Customer Chief Says

18. Sept. 2025, 21:17 UTC

Ergebnisse

FedEx Profit, Sales Rise on Improvement in U.S. Shipping -- 2nd Update

18. Sept. 2025, 21:07 UTC

Ergebnisse

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18. Sept. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. Sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18. Sept. 2025, 20:50 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

18. Sept. 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

18. Sept. 2025, 20:22 UTC

Akquisitionen, Fusionen, Übernahmen

UPS Cites Inability of All Closing Conditions to Be Satisfied

18. Sept. 2025, 20:22 UTC

Akquisitionen, Fusionen, Übernahmen

United Parcel Service Terminates Plan to Buy Estafeta

18. Sept. 2025, 20:20 UTC

Akquisitionen, Fusionen, Übernahmen

Here's How Much the U.S. Has Made on Its Intel Stock Purchase -- Barrons.com

18. Sept. 2025, 20:18 UTC

Ergebnisse

Nucor Stock Falls After Earnings. Why Its Guidance Was Far Off Rival Steel Dynamics. -- Barrons.com

18. Sept. 2025, 20:18 UTC

Ergebnisse

Bullish Crushes Earnings. The Crypto Stock Pops. -- Barrons.com

18. Sept. 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18. Sept. 2025, 20:07 UTC

Ergebnisse

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18. Sept. 2025, 20:03 UTC

Ergebnisse

FedEx 1Q FedEx Freight Segment Revenue $2.26B >FDX

Peer-Vergleich

Kursveränderung

Moleculin Biotech Inc Prognose

Kursziel

By TipRanks

1702.7% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD  1702.7%

Hoch 12 USD

Tief 4 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Moleculin Biotech Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

$

help-icon Live chat